Cyclic AMP-Specific Phosphodiesterase 4 Inhibitors Promote ABCA1 Expression and Cholesterol Efflux
- 18 January 2002
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 290 (2), 663-669
- https://doi.org/10.1006/bbrc.2001.6259
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolismGastroenterology, 2001
- Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutationsAtherosclerosis, 2000
- Functional Loss of ABCA1 in Mice Causes Severe Placental Malformation, Aberrant Lipid Distribution, and Kidney Glomerulonephritis As Well As High-Density Lipoprotein Cholesterol DeficiencyThe American Journal of Pathology, 2000
- The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathwayJCI Insight, 1999
- Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol effluxThe Lancet, 1999
- Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiencyNature Genetics, 1999
- The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier diseaseNature Genetics, 1999
- Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1Nature Genetics, 1999
- 5 High-density lipoprotein: A major risk factor for coronary atherosclerosisBailliere's Clinical Endocrinology and Metabolism, 1987
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975